|
Play Video: The Importance of Insider Buying
|
|
|
The table below summarizes the most recent CRVS insider buying information, with links below the price to see the
CAGR achieved by each insider on their purchases. As the saying goes on Wall St., there are many
possible reasons to sell a stock, but only one reason to buy. Watch the importance of insider buying video for more
information about why CRVS insider buys are important for investors to follow.
Date | Insider | Price | Amount |
5-15-2023 Insider Buy |
Linda Grais
|
$2.45
CAGR »
|
$24,500.00 10,000 shares |
12-20-2022 Insider Buy |
William Benton Jones See Remarks |
$0.79
CAGR »
|
$15,800.00 20,000 shares |
9-28-2022 Insider Buy |
Richard A. Miller, M.D. President and CEO |
$0.76
CAGR »
|
$19,070.00 25,000 shares |
9-20-2022 Insider Buy |
Richard A. Miller, M.D. President and CEO |
$0.81
CAGR »
|
$16,253.23 20,000 shares |
6-27-2022 Insider Buy |
Richard A. Miller, M.D. President and CEO |
$1.01
CAGR »
|
$10,134.50 10,000 shares |
6-6-2022 Insider Buy |
Richard A. Miller, M.D. President and CEO |
$0.98
CAGR »
|
$5,797.20 5,890 shares |
3-17-2022 Insider Buy |
Richard A. Miller, M.D. President and CEO |
$1.49
CAGR »
|
$44,600.00 30,000 shares |
3-17-2022 Insider Buy |
Leiv Lea Chief Financial Officer |
$1.57
CAGR »
|
$77,045.10 49,038 shares |
8-20-2021 Insider Buy |
Richard A. Miller, M.D. President and CEO |
$1.93
CAGR »
|
$19,254.00 10,000 shares |
2-17-2021 Insider Buy |
Richard A. Miller, M.D. President and CEO |
$3.50
CAGR »
|
$350,000.00 100,000 shares |
8-6-2019 Insider Buy |
ORBIMED ADVISORS LLC Director and >10% Owner |
$3.51
CAGR »
|
$500,722.56 142,656 shares |
8-6-2019 Insider Buy |
Peter A. Thompson Director and >10% Owner |
$3.51
CAGR »
|
$500,722.56 142,656 shares |
8-7-2019 Insider Buy |
Richard A. Miller, M.D. President and CEO |
$3.56
CAGR »
|
$26,725.00 7,500 shares |
6-14-2019 Insider Buy |
Richard A. Miller, M.D. President and CEO |
$3.41
CAGR »
|
$40,873.80 12,000 shares |
6-7-2019 Insider Buy |
Leiv Lea Chief Financial Officer |
$3.49
CAGR »
|
$88,980.00 25,500 shares |
12-27-2018 Insider Buy |
Richard A. Miller, M.D. President and CEO |
$3.29
CAGR »
|
$65,884.00 20,000 shares |
12-21-2018 Insider Buy |
Leiv Lea Chief Financial Officer |
$4.15
CAGR »
|
$102,408.67 24,700 shares |
12-20-2018 Insider Buy |
Richard A. Miller, M.D. President and CEO |
$4.39
CAGR »
|
$43,950.00 10,000 shares |
12-6-2018 Insider Buy |
Richard A. Miller, M.D. President and CEO |
$5.99
CAGR »
|
$29,934.00 5,000 shares |
12-4-2018 Insider Buy |
Richard A. Miller, M.D. President and CEO |
$5.95
CAGR »
|
$8,936.90 1,502 shares |
3-12-2018 Insider Buy |
ORBIMED ADVISORS LLC Director and >10% Owner |
$8.50
CAGR »
|
$4,999,997.50 588,235 shares |
3-12-2018 Insider Buy |
Peter A. Thompson Director and >10% Owner |
$8.50
CAGR »
|
$4,999,997.50 588,235 shares |
3-12-2018 Insider Buy |
Holdings A/S Novo >10% Owner |
$8.50
CAGR »
|
$9,999,995.00 1,176,470 shares |
3-12-2018 Insider Buy |
Terry P. Gould Director and >10% Owner |
$8.50
CAGR »
|
$4,999,997.50 588,235 shares |
3-12-2018 Insider Buy |
ADAMS STREET PARTNERS LLC >10% Owner |
$8.50
CAGR »
|
$4,999,997.50 588,235 shares |
11-20-2017 Insider Buy |
Richard A. Miller, M.D. President and CEO |
$10.79
CAGR »
|
$107,850.00 10,000 shares |
6-23-2017 Insider Buy |
Holdings A/S Novo >10% Owner |
$10.95
CAGR »
|
$219,000.00 20,000 shares |
6-13-2017 Insider Buy |
Richard A. Miller, M.D. President and CEO |
$9.88
CAGR »
|
$247,083.62 25,000 shares |
6-24-2016 Insider Buy |
ORBIMED ADVISORS LLC Director and >10% Owner |
$12.98
CAGR »
|
$12,983.00 1,000 shares |
6-24-2016 Insider Buy |
Peter A. Thompson Director and >10% Owner |
$12.98
CAGR »
|
$12,983.00 1,000 shares |
6-21-2016 Insider Buy |
ORBIMED ADVISORS LLC Director and >10% Owner |
$12.74
CAGR »
|
$489,192.21 38,383 shares |
6-21-2016 Insider Buy |
Peter A. Thompson Director and >10% Owner |
$12.74
CAGR »
|
$489,192.21 38,383 shares |
6-16-2016 Insider Buy |
ORBIMED ADVISORS LLC Director and >10% Owner |
$12.35
CAGR »
|
$247,000.00 20,000 shares |
6-16-2016 Insider Buy |
Peter A. Thompson Director and >10% Owner |
$12.35
CAGR »
|
$247,000.00 20,000 shares |
6-10-2016 Insider Buy |
ORBIMED ADVISORS LLC Director and >10% Owner |
$12.96
CAGR »
|
$648,100.00 50,000 shares |
6-10-2016 Insider Buy |
Peter A. Thompson Director and >10% Owner |
$12.96
CAGR »
|
$648,100.00 50,000 shares |
5-20-2016 Insider Buy |
Peter A. Thompson Director and >10% Owner |
$13.09
CAGR »
|
$61,732.44 4,716 shares |
5-20-2016 Insider Buy |
ORBIMED ADVISORS LLC Director and >10% Owner |
$13.09
CAGR »
|
$61,732.44 4,716 shares |
5-19-2016 Insider Buy |
ORBIMED ADVISORS LLC Director |
$11.77
CAGR »
|
$80,035.04 6,800 shares |
5-19-2016 Insider Buy |
Peter A. Thompson Director and >10% Owner |
$11.77
CAGR »
|
$80,035.04 6,800 shares |
5-13-2016 Insider Buy |
Richard A. Miller, M.D. President and CEO |
$10.00
CAGR »
|
$302,981.01 30,300 shares |
5-12-2016 Insider Buy |
A/S Novo >10% Owner |
$10.00
CAGR »
|
$700,000.00 70,000 shares |
3-29-2016 Insider Buy |
A/S Novo >10% Owner |
$15.00
CAGR »
|
$9,999,990.00 666,666 shares |
3-29-2016 Insider Buy |
ORBIMED ADVISORS LLC Director and >10% Owner |
$15.00
CAGR »
|
$8,250,000.00 550,000 shares |
3-29-2016 Insider Buy |
ADAMS STREET PARTNERS LLC >10% Owner |
$15.00
CAGR »
|
$3,000,000.00 200,000 shares |
3-29-2016 Insider Buy |
Peter A. Thompson Director and >10% Owner |
$15.00
CAGR »
|
$8,250,000.00 550,000 shares |
3-29-2016 Insider Buy |
Terry P. Gould Director and >10% Owner |
$15.00
CAGR »
|
$3,000,000.00 200,000 shares |
Also See: Institutional Holders of CRVS
Also See: SEC filings
Below we present the annualized performance delivered by CRVS stock since 5-15-2023 (the date of the most recent
insider purchase). The performance of the investment from the time CRVS insider buying occurred is the ultimate
test of whether insiders were right about CRVS being a good buy.
Growth of $10,000.00
Without Dividends Reinvested
|
Start date: |
05/16/2023 |
|
End date: |
04/29/2024 |
|
Start price/share: |
$2.37 |
|
End price/share: |
$1.58 |
|
Dividends collected/share: |
$0.00 |
|
Total return: |
-33.33% |
|
Annualized Gain: |
-34.86% |
|
Starting investment: |
$10,000.00 |
|
Ending investment: |
$6,667.00 |
|
Years: |
0.96 |
|
CRVS Insider Buying
This Holdings Channel page has presented insider buying activity, covering Directors, officers (such as CEO, CFO, COO, etc.),
and >10% owners (who are required to file form 4's with the SEC). Important institutional owners may not fall under these
categories, but instead file their holdings quarterly on the latest form 13F filings.
While recent CRVS insider buying activity is included, there may also be stock sales over this same period (Also See: SEC filings for sales and other details).
Also See: Funds Holding CRVS
|
|